Carbamazepin is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Upsher-smith Laboratories, Llc. The primary component is Carbamazepine.
| Product ID | 0832-6023_aadc79a0-f144-46e3-b324-17dbc422f5a1 |
| NDC | 0832-6023 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Carbamazepin |
| Generic Name | Carbamazepine |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-04-13 |
| Marketing Category | ANDA / |
| Application Number | ANDA213311 |
| Labeler Name | Upsher-Smith Laboratories, LLC |
| Substance Name | CARBAMAZEPINE |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-04-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-0109 | Carbamazepine | Carbamazepine |
| 0093-0778 | Carbamazepine | Carbamazepine |
| 0093-0090 | Epitol | Carbamazepine |
| 0078-0508 | Tegretol | carbamazepine |
| 0078-0509 | Tegretol | carbamazepine |
| 0078-0510 | Tegretol | carbamazepine |
| 0078-0511 | Tegretol | carbamazepine |
| 0078-0512 | Tegretol | carbamazepine |